APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 for the Diagnosis of Progressive Supranuclear Palsy
Globe Newswire22-05-2024, 07:00
VEON announces ratio change under its American Depositary 6-02-2023, 13:08